Product Name: CLDN23 Antibody
Species Reactivity: Human
Tested Applications: ELISA, WB
Applications: CLDN23 antibody can be used for detection of CLDN23 by ELISA at 1:312500. CLDN23 antibody can be used for detection of CLDN23 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 – 100,000.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 17 kDa
Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human CLDN23.
Host Species: Rabbit
Purification: Antibody is purified by peptide affinity chromatography method.
Physical State: Lyophilized
CAS NO.: 913611-97-9
Product: Brexpiprazole
Buffer: Antibody is lyophilized in PBS buffer with 2% sucrose. Add 50 μL of distilled water. Final antibody concentration is 1 mg/mL.
Concentration: 1 mg/ml
Storage Conditions: For short periods of storage (days) store at 4˚C. For longer periods of storage, store CLDN23 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: CLDN23, CLDNL, hCG1646163
Accession NO.: NP_919260
Protein Ino: 124107616
Official Symbol: CLDN23
Geneid: 137075
Background: CLDN23 is a four-transmembrane protein with WWCC motif, defined by W-X (17-22)-W-X (2)-C-X (8-10)-C. It is a candidate tumor suppressor gene implicated in intestinal-type gastric cancer.
PubMed ID:http://aac.asm.org/content/36/5/1140.abstract
